This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Journalology/ Peer Review/ Authorship  • Health Policy  • Law and Medicine  • Men's Health, Other  • Alert me on articles by topic

Call for Papers

Phil B. Fontanarosa, MD, MBA; Helene M. Cole, MD

JAMA. 2006;295:440-441.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Gender-based medicine—specifically recognizing and understanding differences in the health of men and women—drew much attention in the 1990s. The National Institutes of Health's Office of Research on Women's Health was established in 1990.¹ The inclusion of women (and minorities) in clinical trials in sufficient number to allow analysis of differences in intervention effect became public law when Congress made this provision part of the NIH Revitalization Act of 1993 (Pub L No. 103-43).² With seemingly similar purpose, the US Food and Drug Administration (FDA) issued a guideline in 1993³ that emphasized the importance of including both men and women in clinical trials evaluating new medications, and in 1994 the FDA created an Office of Women's Health.⁴ Over the past decade, there has been a dramatic increase in the quantity and quality of research devoted to examining numerous aspects of women's health . . . [Full Text of this Article]

Author Affiliations: Dr Fontanarosa is Executive Deputy Editor (phil.fontanarosa@jama-archives.org) and Dr Cole is Contributing Editor, JAMA.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Midlife Risk Factors and Healthy Survival in Men.
Willcox et al.
JAMA 2006;296:2343-2350.
ABSTRACT | FULL TEXT  

Improving Men's Health: Evidence and Opportunity.
Fontanarosa and Cole
JAMA 2006;296:2373-2375.
FULL TEXT